Fengze Wang

机构：Chengdu University, Neusoft (China), Chengdu Neusoft University · ORCID：0000-0002-8347-8004

发表论文 19 篇 · 总被引 725 次 · h-index 8

代表论文

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials (2021 · The Lancet Infectious Diseases · 被引 456)
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 (2021 · Nature Communications · 被引 81)
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants (2021 · Nature Communications · 被引 68)
A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core (2022 · EBioMedicine · 被引 32)
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials (2020 · medRxiv · 被引 23)
Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants (2022 · Emerging Microbes & Infections · 被引 18)